Skip to main content
. 2012 Aug 17;41(5):1570–1576. doi: 10.3892/ijo.2012.1590

Table I.

Immunoexpression of MSC markers in patients with or without disease recurrence.

Disease stage Immunoexpression of MSC markers
CD133 (%) ABCB5 (%) CD166 (%) Nestin (%)
Group I: no recurrence (n=18) 5/18 (27) 8/18 (44) 10/18 (55) 16/18 (88)
Group II: recurrence (n=18) 11/18a(61) 9/17 (52) 9/18 (50) 15/18 (83)
a

p<0.02 (Fisher’s exact test); p<0.025 (Odds ratio analysis). Relative risk of CD133 overexpression = 2.2.